David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
CMS Energy
CMS
$21.6B
| $15.8M | 0.01% |
203,828
+103,922
| +104% | +$7.71M |
|
1227
Madrigal Pharmaceuticals
MDGL
$11.8B
| $15.8M | 0.01% |
30,139
-58,415
| -66% | -$27.9M |
|
1228
Vermilion Energy
VET
$1.86B
| $15.7M | 0.01% |
1,139,234
+836,083
| +276% | +$8.86M |
|
1229
Ligand Pharmaceuticals
LGND
$5.62B
| $15.7M | 0.01% |
78,428
+41,877
| +115% | +$8.29M |
|
1230
CALL
Walt Disney
DIS
$192B
| $15.6M | 0.01% |
162,100
-248,200
| -60% | -$26.2M |
|
1231
Liberty Global Class A
LBTYA
$3.68B
| $15.6M | 0.01% |
1,292,117
+819,543
| +173% | +$9.54M |
|
1232
CALL
Madison Square Garden
MSGS
$9.8B
| $15.6M | 0.01% |
48,500
+38,500
| +385% | +$11.5M |
|
1233
HEICO Corp
HEI
$49.1B
| $15.6M | 0.01% |
56,794
-148,341
| -72% | -$47.8M |
|
1234
Toyota
TM
$228B
| $15.6M | 0.01% |
+75,537
| New | +$17.1M |
|
1235
Ambev
ABEV
$45.2B
| $15.5M | 0.01% |
5,310,370
+377,351
| +8% | +$1.08M |
|
1236
FIGS
FIGS
$2.44B
| $15.5M | 0.01% |
1,048,907
-247,079
| -19% | -$3.17M |
|
1237
Lyft
LYFT
$6.68B
| $15.5M | 0.01% |
1,164,374
-388,943
| -25% | -$6.02M |
|
1238
Theravance Biopharma
TBPH
$884M
| $15.5M | 0.01% |
954,042
-305,899
| -24% | -$5.41M |
|
1239
Mirum Pharmaceuticals
MIRM
$5.98B
| $15.5M | 0.01% |
167,489
-780,672
| -82% | -$73.4M |
|
1240
Ouster
OUST
$2.61B
| $15.5M | 0.01% |
842,089
-10,317
| -1% | -$225K |
|
1241
Ezcorp Inc
EZPW
$2.16B
| $15.5M | 0.01% |
609,392
+50,640
| +9% | +$1.21M |
|
|
INGM
1242
Ingram Micro Holding
INGM
$6.69B
| $15.4M | 0.01% |
662,473
+619,915
| +1,457% | +$13.5M |
|
1243
Grab
GRAB
$14.6B
| $15.4M | 0.01% |
4,217,713
-20,699,811
| -83% | -$87.8M |
|
|
GPAT
1244
GP-Act III Acquisition Corp
GPAT
| $15.4M | 0.01% |
1,423,125
| – | – |
|
|
JAN
1245
Janus Living Inc
JAN
$7.35B
| $15.4M | 0.01% |
+653,500
| New | +$15.3M |
|
|
TPH
1246
DELISTED
Tri Pointe Homes
TPH
| $15.4M | 0.01% |
329,123
-1,000,040
| -75% | -$40.7M |
|
1247
Adtran
ADTN
$653M
| $15.3M | 0.01% |
1,218,969
+20,196
| +2% | +$205K |
|
1248
PUT
Celsius Holdings
CELH
$8.94B
| $15.3M | 0.01% |
431,400
-607,200
| -58% | -$28.8M |
|
1249
CALL
Whirlpool
WHR
$2.65B
| $15.2M | 0.01% |
282,800
+24,700
| +10% | +$1.81M |
|
1250
CALL
Quanta Services
PWR
$90.8B
| $15.2M | 0.01% |
27,700
-16,700
| -38% | -$8.6M |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.